Literature DB >> 15476949

Genetic variations at urotensin II and urotensin II receptor genes and risk of type 2 diabetes mellitus in Japanese.

Susumu Suzuki1, Zong Wenyi, Masashi Hirai, Yoshinori Hinokio, Chitose Suzuki, Takahiro Yamada, Shinsuke Yoshizumi, Michiko Suzuki, Yukio Tanizawa, Akira Matsutani, Yoshitomo Oka.   

Abstract

Urotensin II is among the most potent vasoactive hormones known and the urotensin II (UTS2) gene is localized to 1p36-p32, one of the regions reported to show possible linkage with type 2 diabetes in Japanese. When we surveyed genetic polymorphisms in the UTS2 and urotensin II receptor (GPR14) gene, we identified two SNPs with amino acid substitutions (designated T21M and S89N and an SNP in the promotor region (-605G>A) of the UTS2 gene, and two SNPs in the non-coding region of the GPR14 gene. We then studied these three SNPs in the UTS2 gene and two SNPs in the GPR14 gene in 152 Japanese subjects with type 2 diabetes mellitus and two control Japanese populations. The allele frequency of 89N was significantly higher in type 2 diabetic patients than in both elderly normal subjects (P = 0.0018) and subjects with normal glucose tolerance (P = 0.0011), whereas the allele frequency of T21M and -605G>A in the UTS2 gene and those of two SNPs in the GPR14 gene were essentially identical in these three groups. Furthermore, in the subjects with normal glucose tolerance, 89N was associated with significantly higher insulin levels on oral glucose tolerance test, suggesting reduced insulin sensitivity in subjects with 89N. These results strongly suggest that subjects with S89N in the UTS2 gene are more insulin-resistant and thus more susceptible to type 2 diabetes mellitus development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15476949     DOI: 10.1016/j.peptides.2004.03.030

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  13 in total

1.  The role of the UTS2 gene polymorphisms and plasma Urotensin-II levels in breast cancer.

Authors:  Onder Yumrutas; Serdar Oztuzcu; Hakan Büyükhatipoglu; Ibrahim Bozgeyik; Esra Bozgeyik; Yusuf Ziya Igci; Haydar Bagis; M Ozgur Cevik; M Emin Kalender; Zeynep Eslik; Ahmet Arslan
Journal:  Tumour Biol       Date:  2015-01-22

2.  Loss of urotensin II receptor diminishes hyperglycemia and kidney injury in streptozotocin-treated mice.

Authors:  Dieniffer Peixoto-Neves; Praghalathan Kanthakumar; Ravi Kumar; Hitesh Soni; Adebowale Adebiyi
Journal:  J Mol Endocrinol       Date:  2022-03-25       Impact factor: 4.869

3.  Effect of the urotensin-II receptor antagonist palosuran on secretion of and sensitivity to insulin in patients with Type 2 diabetes mellitus.

Authors:  Patricia N Sidharta; Klaus Rave; Lutz Heinemann; Eleonora Chiossi; Stephan Krähenbühl; Jasper Dingemanse
Journal:  Br J Clin Pharmacol       Date:  2009-10       Impact factor: 4.335

4.  Hemodynamic effects of chronic urotensin II administration in animals with and without aorto-caval fistula.

Authors:  Gregory S Harris; Robert M Lust; Laxmansa C Katwa
Journal:  Peptides       Date:  2007-05-06       Impact factor: 3.750

Review 5.  Role of urotensin II and its receptor in health and disease.

Authors:  John McDonald; Madura Batuwangala; David G Lambert
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

6.  Raised plasma urotensin II in type 2 diabetes patients is associated with the metabolic syndrome phenotype.

Authors:  Damien Gruson; Michel F Rousseau; Jean-Marie Ketelslegers; Michel P Hermans
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-08       Impact factor: 3.738

7.  Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures.

Authors:  Francesco Merlino; Salvatore Di Maro; Ali Munaim Yousif; Michele Caraglia; Paolo Grieco
Journal:  J Amino Acids       Date:  2013-02-25

8.  A closer look at the role of urotensin II in the metabolic syndrome.

Authors:  Pierre-Olivier Barrette; Adel Giaid Schwertani
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-28       Impact factor: 5.555

9.  Association analysis of urotensin II gene (UTS2) and flanking regions with biochemical parameters related to insulin resistance.

Authors:  María E Sáez; Tarik Smani; Reposo Ramírez-Lorca; Ignacio Díaz; Manuel Serrano-Ríos; Agustín Ruiz; Antonio Ordoñez
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

10.  Potential Clinical Implications of the Urotensin II Receptor Antagonists.

Authors:  Philip Tsoukas; Emilie Kane; Adel Giaid
Journal:  Front Pharmacol       Date:  2011-07-22       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.